Status:
RECRUITING
Acute Myeloid Leukemia Registry
Lead Sponsor:
Turkish Hematology Association
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to this study.
Detailed Description
This is a non interventional prospective disease registry, 250 prospective patients diagnosed with AML across 20 centers in Turkey. Participating sites will consist of hematology clinics and routine ...
Eligibility Criteria
Inclusion
- Diagnosed as AML after 1 Jan 2020
- Patients signed informed consent form
Exclusion
- Patients under 18 years old
Key Trial Info
Start Date :
December 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 21 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05979675
Start Date
December 21 2021
End Date
December 21 2026
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antalya Training and Research Hospital
Antalya, Turkey (Türkiye)